Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
Needham has upgraded Personalis Inc (NASDAQ:PSNL) to Buy from Hold with a price target of $8. The analyst writes that Personalis’s cash…
PayPal Analyst Downgrades Stock Citing Branded Checkout Market Share Loss To Apple Pay
Raymond James analyst John Davis downgraded PayPal Holdings Inc (NASDAQ:PYPL) from Outperform to Market Perform. PayPal’s strong start in 2023 versus the…
China Fully Removes Macau Travel Restrictions, COVID-19 Testing Requirements: Here’s How To Play It
On Monday, China officially lifted all travel restrictions and limitations to Macau and scrapped COVID-19 texting requirements.
Macau casino operators are now hoping the end of pandemic restrictions will produce an extended period of pent-up demand among gamblers.
Sage Therapeutics-Biogen Partnered Depression Candidate Under Priority FDA Review, Analyst Says Its ‘Incrementally Positive’
The FDA has accepted for review a marketing application seeking approval for Sage Therapeutics Inc (NASDAQ:SAGE) and Biogen Inc’s (NASDAQ:BIIB) zuranolone for major depressive…
RH Found ‘Several Mistakes’: Analyst Downgrades Stock After Friday’s Proxy Filing
Shares of Restoration Hardware, or RH (NYSE: RH), experienced a significant drop of 7.53% on Monday, in response to the recent disclosures the home furniture company made on Feb. 3.
Buy Splunk, Sell Datadog: Analyst Lays Out 2023 Strategy For IT Investors
There is likely to be a slowdown in enterprise software spending growth in 2023. “Commentary by IT buyers, vendors, and channel partners suggests very low IT purchasing in the first half,” according to KeyBanc Capital Markets.
Why These Uber Analysts Are Bullish Ahead Of Q4 Earnings
Uber Technologies Inc. (NYSE: UBER) will issue its fourth-quarter 2022 earnings on Feb. 8 before market open, here’s what the Street is expecting.
Analyst Says Be Careful With Big Tech Stocks: ‘Nothing In This Space Is Cheap Anymore’
Tech stocks are off to a hot start in 2023 after a horrible year in 2022.
Cantor Fitzgerald Drops Coverage On These 3 Marijuana Stocks
Cantor Fitzgerald’s Pablo Zaunic discontinued research coverage of Aleafia Health (OTCQB: ALEAF), Flora Growth (NASDAQ: FLGC) and Auxly Cannabis (OTCQB: CBWTF).&n
Shiba Inu Zoomie Ahead? Analyst Who Nailed Bitcoin 2021 Cycle Expects Meme Coin ‘Hype To Pick Up’ In Few Weeks
A pseudonymous crypto analyst who correctly predicted the end of Bitcoin's (CRYPTO: BTC) bull market in 2021, believes that Shiba Inu (CRYPTO: SHIB) may be on the cusp of a strong bullish streak in the coming weeks.